Literature DB >> 2670845

Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme.

L Christensen1, I Clemmensen.   

Abstract

A recently discovered human plasma protein, tetranectin (TN), which has previously been demonstrated immunohistochemically within various endocrine tissues, was in this study identified in an additional number of epithelial and mesenchymal cells by two polyclonal antibodies and one monoclonal using the conventional immunoperoxidase staining technique and a modification of the CLONO-GLAD procedure. TN was found in endothelial and epithelial tissues, particularly in cells with a high turn-over or storage function such as gastric parietal and zymogenic cells, absorptive surface epithelium of the small intestine, ducts of exocrine glands and pseudostratified respiratory epithelium. Also mesenchymal cells produced a TN positive staining reaction, which was most conspicuous in mast cells, but also present in some lymphocytes, plasma cells, macrophages, granulocytes, striated and smooth muscle cells and fibroblasts. SDS-PAGE and Western blotting analysis of cultured human embryonal fibroblasts (WI-38) showed that the cells besides TN contain another protein with a molecular weight of 82,000. As this protein, however, reacted with our affinity purified antibodies it probably represents a precursor of TN or a protein with a molecular weight of approximately 60,000, which is covalently linked to TN. This and the fact that TN shows amino acid sequence homologies to the carboxyterminal part of the asialo-glycoprotein receptor and a cartilage proteoglycan core protein as well a binding affinity to plasminogen points to TN as being part of a larger molecule, which possibly has been cleaved by proteolysis at the cellular site and then passed into the blood, where it polymerizes into a tetramer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670845     DOI: 10.1007/bf00495012

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  27 in total

1.  Tissue-type plasminogen activator in rat adrenal medulla.

Authors:  P Kristensen; D M Hougaard; L S Nielsen; K Danø
Journal:  Histochemistry       Date:  1986

2.  Partial cDNA sequence encoding a globular domain at the C terminus of the rat cartilage proteoglycan.

Authors:  K Doege; P Fernandez; J R Hassell; M Sasaki; Y Yamada
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

3.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.

Authors:  J W McLean; J E Tomlinson; W J Kuang; D L Eaton; E Y Chen; G M Fless; A M Scanu; R M Lawn
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

4.  Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein.

Authors:  K Drickamer; M S Dordal; L Reynolds
Journal:  J Biol Chem       Date:  1986-05-25       Impact factor: 5.157

5.  Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.

Authors:  I Clemmensen; L C Petersen; C Kluft
Journal:  Eur J Biochem       Date:  1986-04-15

6.  Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues.

Authors:  L Christensen; N Johansen; B A Jensen; I Clemmensen
Journal:  Histochemistry       Date:  1987

7.  Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core protein.

Authors:  J Fuhlendorff; I Clemmensen; S Magnusson
Journal:  Biochemistry       Date:  1987-10-20       Impact factor: 3.162

8.  Plasminogen activators of the pituitary gland: enzyme characterization and hormonal modulation.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Cell Biol       Date:  1983-10       Impact factor: 10.539

9.  Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse.

Authors:  L I Larsson; L Skriver; L S Nielsen; J Grøndahl-Hansen; P Kristensen; K Danø
Journal:  J Cell Biol       Date:  1984-03       Impact factor: 10.539

10.  Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland.

Authors:  P Kristensen; L S Nielsen; J Grøndahl-Hansen; P B Andresen; L I Larsson; K Danø
Journal:  J Cell Biol       Date:  1985-07       Impact factor: 10.539

View more
  12 in total

1.  Tetranectin, a trimeric plasminogen-binding C-type lectin.

Authors:  T L Holtet; J H Graversen; I Clemmensen; H C Thøgersen; M Etzerodt
Journal:  Protein Sci       Date:  1997-07       Impact factor: 6.725

2.  Expression and prognostic significance of Tetranectin in invasive and non-invasive bladder cancer.

Authors:  A Brunner; C Ensinger; M Christiansen; S Heiss; I Verdorfer; G Mikuz; A Tzankov
Journal:  Virchows Arch       Date:  2007-04-13       Impact factor: 4.064

3.  The heparin-binding site in tetranectin is located in the N-terminal region and binding does not involve the carbohydrate recognition domain.

Authors:  R H Lorentsen; J H Graversen; N R Caterer; H C Thogersen; M Etzerodt
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

4.  Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase.

Authors:  N Borregaard; L Christensen; O W Bejerrum; H S Birgens; I Clemmensen
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

5.  Differences in tetranectin immunoreactivity between benign and malignant breast tissue.

Authors:  L Christensen; I Clemmensen
Journal:  Histochemistry       Date:  1991

6.  Stimulus-dependent secretion of plasma proteins from human neutrophils.

Authors:  N Borregaard; L Kjeldsen; K Rygaard; L Bastholm; M H Nielsen; H Sengeløv; O W Bjerrum; A H Johnsen
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Mouse tetranectin: cDNA sequence, tissue-specific expression, and chromosomal mapping.

Authors:  K Ibaraki; C A Kozak; U M Wewer; R Albrechtsen; M F Young
Journal:  Mamm Genome       Date:  1995-10       Impact factor: 2.957

8.  Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis.

Authors:  E F Kamper; L T Kopeikina; P Trontzas; N C Kyriazis; G Vaiopoulos; J Stavridis
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

9.  Aberrant tetranectin expression in human breast carcinomas as a predictor of survival.

Authors:  P Obrist; G Spizzo; C Ensinger; D Fong; T Brunhuber; G Schäfer; M Varga; R Margreiter; A Amberger; G Gastl; M Christiansen
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

10.  A potential role for tetranectin in mineralization during osteogenesis.

Authors:  U M Wewer; K Ibaraki; P Schjørring; M E Durkin; M F Young; R Albrechtsen
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.